Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
白色念珠菌口腔感染塑造先天免疫和骨髓源性抑制细胞的募集
基本信息
- 批准号:10501899
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-14 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:Adoptive Cell TransfersAdoptive TransferAspartic EndopeptidasesBacterial InfectionsBenignCancer EtiologyCandida albicansCellsComplexCuesDiseaseEnzymesEpithelialEpithelial AttachmentEpithelial CellsEquilibriumFutureGoalsHumanHyphaeImageImmuneImmune responseImmunityImmunologic FactorsIn VitroIndividualIndustrial fungicideInfectionInflammatoryInflammatory ResponseIntegration Host FactorsInterleukin-1Interleukin-17IntestinesInvadedKininogenaseLTB4R geneLeadLeukotriene B4Macrophage-1 AntigenMeasuresMediatingModelingMucosal ImmunityMucous MembraneMusMycosesMyeloid-derived suppressor cellsNatural ImmunityNeutrophil InfiltrationNutrientOralOral candidiasisOral cavityOrganismOutcomePathogenesisPeptide HydrolasesPersonsProductionProteinsRoleShapesSignal TransductionSymptomsT-LymphocyteThickTissuesTongueTumor EscapeVirulencearginasearmchronic infectioncytokinefungusgranulocytegut microbiomeimmune activationin vivoin vivo evaluationmouse modelmucosal sitemutantneutrophilnoveloral cavity epitheliumoral infectionoropharyngeal thrushoverexpressionpathogenpathogenic fungusrecruit
项目摘要
Project Summary
Candida albicans is a fungal commensal organism that causes oropharyngeal candidiasis (OPC) and
may disseminate systemically in immune compromised people. However, most healthy people have
oral
levels of C. albicans and it is a beneficial organism in the human gut microbiome. Mice infected with C.
albicans also have low numbers of oral fungi but have much higher numbers of
C. albicans in the gut so
that they are a good model to study what factors permit fungal tolerance at human mucosal sites.
C. albicans hyphae secrete the aspartyl protease Sap6 that mediates virulence in OPC, induces cytokine
release from oral epithelial cells, and initiates neutrophil recruitment. Oral infection by C. albicans in mice
caused recruitment of neutrophil “swarms” surrounding invading hyphae, as well as localized Arginase1
positive (Arg1+) granulocytic cells. These Arg1+ cells showed suppression of T cells thus identifying them
as myeloid-derived suppressor cells (MDSC). MDSCs have a well-known immunosuppressive role in
cancer causing tumor immune evasion, but also have a major role in host immune responses to bacterial
and fungal infections by favoring pathogen persistence and chronic infection. We are the first to identify
MDSC recruitment upon C. albicans oral infection but we do not know their role here. C. albicans infection
resulted in changes the oral epithelium (Ep) including expression of kallikrein (KLK5) proteases
accompanying increased Ep desquamation, and increased levels of tissue Arginase 1 (Arg1). The Aims
of this project are to 1) Identify in what manner Arg1 and KLK5 expression in oral Ep alters C. albicans
infection by examining the effect of Arg1 and KLK5 depletion; 2) Determine how C. albicans induces
neutrophil swarming and recruitment of MDSCs in vitro by using live imaging of neutrophil swarming
induced by C. albicans and Sap6 and to measure fungicidal activity of MDSCs; and 3) Ascertain the
contribution of MDSCs in oral and gut Ca infection in vivo by comparing C. albicans infection in tongue
and intestine following MDSC depletion or adoptive transfer of MDSCs. The goal of this proposal is to
determine the function of MDSCs in mucosal immunity as well as how Arginase metabolites and KLK5
expression control the final outcome of fungal infection. It is proposed that MDSCs are a novel and
unexplored arm of oral epithelial immunity that contribute to oral or gut tolerance of fungal pathogens.
The long-range goal of this project is to understand host response to C. albicans and that will guide future
strategies to reduce the immune escape of C. albicans and add to our understanding of host tolerance.
项目概要
白色念珠菌是一种真菌共生生物,可引起口咽念珠菌病 (OPC) 和
可能会在免疫功能低下的人群中进行系统性传播,但是大多数健康人都会出现这种情况。
口服
白色念珠菌水平,它是感染念珠菌的小鼠肠道微生物组中的有益生物。
白色念珠菌的口腔真菌数量也较少,但口腔真菌数量却要高得多
肠道中的白色念珠菌
它们是研究哪些因素允许人类粘膜部位真菌耐受的良好模型。
白色念珠菌菌丝分泌天冬氨酰蛋白酶 Sap6,介导 OPC 毒力,诱导细胞因子
从口腔上皮细胞中释放,并引发小鼠白色念珠菌口腔感染。
引起入侵菌丝周围中性粒细胞“群”的募集,以及局部精氨酸酶1
阳性 (Arg1+) 粒细胞。这些 Arg1+ 细胞表现出 T 细胞抑制,从而识别它们。
众所周知,骨髓源性抑制细胞 (MDSC) 具有免疫抑制作用。
癌症导致肿瘤免疫逃避,但也在宿主对细菌的免疫反应中发挥重要作用
和真菌感染,通过促进病原体持久性和慢性感染,我们是第一个发现的。
MDSC 在白色念珠菌口腔感染时招募,但我们不知道它们在白色念珠菌感染中的作用。
导致口腔上皮 (Ep) 发生变化,包括激肽释放酶 (KLK5) 蛋白酶的表达
伴随着 Ep 脱屑的增加和组织精氨酸酶 1 (Arg1) 水平的增加。
该项目的目标是 1) 确定口腔 Ep 中 Arg1 和 KLK5 的表达以何种方式改变白色念珠菌
通过检查 Arg1 和 KLK5 消耗的影响来确定感染;2) 确定白色念珠菌如何诱导;
使用中性粒细胞群实时成像进行体外中性粒细胞群和 MDSC 募集
由白色念珠菌和 Sap6 诱导并测量 MDSC 的杀菌活性;3) 确定
通过比较舌中白色念珠菌感染,了解 MDSC 在口腔和肠道 Ca 感染中的作用
MDSC 耗尽或 MDSC 过继转移后的肠道和肠道 本提案的目标是
确定 MDSC 在粘膜免疫中的功能以及精氨酸酶代谢物和 KLK5 的作用
MDSCs 的表达控制着真菌感染的最终结果。
口腔上皮免疫中尚未探索的部分,有助于口腔或肠道对真菌病原体的耐受性。
该项目的长期目标是了解宿主对白色念珠菌的反应,这将指导未来
减少白色念珠菌免疫逃逸并增加我们对宿主耐受性的理解的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mira Edgerton其他文献
Mira Edgerton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mira Edgerton', 18)}}的其他基金
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
白色念珠菌口腔感染塑造先天免疫和骨髓源性抑制细胞的招募
- 批准号:
10665797 - 财政年份:2022
- 资助金额:
$ 38万 - 项目类别:
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
白色念珠菌分泌的蛋白酶 Sap6 与上皮蛋白酶激活受体 PAR2 和 NLRP3 结合
- 批准号:
10300121 - 财政年份:2021
- 资助金额:
$ 38万 - 项目类别:
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
白色念珠菌分泌的蛋白酶 Sap6 与上皮蛋白酶激活受体 PAR2 和 NLRP3 结合
- 批准号:
10428637 - 财政年份:2021
- 资助金额:
$ 38万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2449485 - 财政年份:1999
- 资助金额:
$ 38万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6634566 - 财政年份:1999
- 资助金额:
$ 38万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6164397 - 财政年份:1999
- 资助金额:
$ 38万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6362916 - 财政年份:1999
- 资助金额:
$ 38万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6516337 - 财政年份:1999
- 资助金额:
$ 38万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2634147 - 财政年份:1997
- 资助金额:
$ 38万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2015439 - 财政年份:1997
- 资助金额:
$ 38万 - 项目类别:
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Role of eosinophil cationic proteins in cardiac hypertrophy
嗜酸性粒细胞阳离子蛋白在心脏肥大中的作用
- 批准号:
10735136 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
- 批准号:
10664134 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别: